Changzhou Sunlight Pharmaceutical Co. Ltd.

Form 483 issued May 31, 2024 · Changzhou, China

Inspection
May 27 – May 31, 2024
Observations
1
Pages
1
FEI number
3003662818

In short: On May 31, 2024, FDA issued a Form 483 with 1 observation to Changzhou Sunlight Pharmaceutical Co. Ltd. in Changzhou, Jiangsu (FEI 3003662818) after an inspection that ran May 27 – May 31, 2024. The investigators were Kshitij A. Patkar and Robin P. Mathew. Most observations concern production; the most-cited regulation is 21 CFR 211.100 (written procedures; deviations).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.100 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Equipment used in the manufacturing of API(active pharmaceutical ingredient) intermediates is not operating at the| appropriate…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Changzhou Sunlight Pharmaceutical Co. Ltd.?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.100 (written procedures; deviations). The opening words of each observation are shown on this page.

Who inspected Changzhou Sunlight Pharmaceutical Co. Ltd.?

Kshitij A. Patkar and Robin P. Mathew are named on this Form 483, for the inspection of May 27 – May 31, 2024. Each investigator has a profile showing what they cite most.

When was Changzhou Sunlight Pharmaceutical Co. Ltd. inspected by FDA?

The inspection ran May 27 – May 31, 2024, and the Form 483 is dated May 31, 2024.

How do I get the full Form 483 for Changzhou Sunlight Pharmaceutical Co. Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free